G. A. Hobbs

Oncology · 2016–2021

A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom G. A. Hobbs trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. C. Der
  2. D. Fruman

Papers from G. A. Hobbs's perspective

Ordered by how strongly the researchers G. A. Hobbs trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Drugging the undruggable Ras: mission possible? (Nature reviews. Drug discovery)
  2. K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions (Nature)
  3. A comprehensive survey of Ras mutations in cancer (Cancer Research)
  4. Fluorouracil, leucovorin, and irinotecan plus cetuximab treatment and RAS mutations in colorectal cancer. (Journal of Clinical Oncology)
  5. Biochemical and Structural Analysis of Common Cancer-Associated KRAS Mutations (Molecular Cancer Research)
  6. A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. (Cell)
  7. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1 (Nature)
  8. Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets (Nature Communications)
  9. PI3K and Cancer: Lessons, Challenges and Opportunities (Nature reviews. Drug discovery)
  10. KRAS: feeding pancreatic cancer proliferation (TIBS -Trends in Biochemical Sciences. Regular ed)

Their papers